Disease / condition

Unspecified Adult Solid Tumor, Protocol Specific clinical trials

Free access to 355 studies·10+ countries·Updated daily4 recruiting
355
Total trials
10+
Countries
10+
Sponsors
4
Recruiting
By phase
Phase 1299
N/A36
Early Phase 112
Phase 25
Phase 32
By status
Completed294
Terminated26
Unknown19
Withdrawn8
Recruiting4
Top countries
United States of America289
United Kingdom9
Canada9
Austria,Belgium,Denmark,France,Germany,Netherlands,Norway,Switzerland,United Kingdom4
New Zealand,United States of America3
Top sponsors
National Cancer In...77
Memorial Sloan Ket...23
City of Hope Medic...17
Roswell Park Cance...13
Case Comprehensive...12
Recent trials
Latest clinical trials for Unspecified Adult Solid Tumor, Protocol Specific
NCT04954599·Phase 1/2Not yet recr...
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University
NCT04842630·Phase 1Recruiting
A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., ...China
NCT03859752·Phase 1Not yet recr...
TR1801-ADC in Patients With Tumors That Express c-Met
Tanabe Research Laboratories U...United States of America
NCT02895490Terminated
Communication Training in Promoting Employment Retention Among Cancer Patients
Virginia Commonwealth Universi...United States of America
NCT02869295·Early Phase 1Completed
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Nektar TherapeuticsUnited States of America
NCT02290522Recruiting
Copenhagen Prospective Personalized Oncology (CoPPO)
Ulrik LassenDenmark
NCT02215928Recruiting
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
Stanford UniversityUnited States of America
NCT02153151Completed
Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy
Sidney Kimmel Cancer Center at...United States of America
NCT02146222·Phase 1Completed
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
University of Wisconsin, Madis...United States of America
NCT02112565·Phase 1Active, not ...
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
City of Hope Medical CenterUnited States of America
NCT02070406·Phase 1Terminated
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer C...United States of America
NCT02055586Completed
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
Case Comprehensive Cancer Cent...United States of America
NCT02033148·Phase 1Withdrawn
Icotinib Hydrochloride in Treating Patients With Advanced Cancers
Roswell Park Cancer Institute
NCT01957995·Phase 1Completed
Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors
University of Southern Califor...United States of America
NCT01828775Completed
Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment
City of Hope Medical CenterUnited States of America
NCT01713972·Phase 1Completed
Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Manisha ShahUnited States of America
NCT01705106·Phase 1Terminated
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
University of ChicagoUnited States of America
NCT01642342·Phase 1Terminated
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
University of Southern Califor...United States of America
NCT01631279·Early Phase 1Terminated
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
Proacta, IncorporatedNew Zealand,United States of America
NCT01612598Completed
Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials
City of Hope Medical CenterUnited States of America
About this record

Access comprehensive clinical trial information for Unspecified Adult Solid Tumor, Protocol Specific through Pure Global AI's free database. This collection includes 355 clinical trials across multiple phases including Phase 1, N/A, Early Phase 1. Currently, 4 trials are actively recruiting participants.

Research for Unspecified Adult Solid Tumor, Protocol Specific is being conducted in United States of America, United Kingdom, Canada and 7+ other countries. Leading sponsors include National Cancer Institute (NCI) and Memorial Sloan Kettering Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 355 clinical trials studying Unspecified Adult Solid Tumor, Protocol Specific, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, City of Hope Medical Center, among others.